|
시장보고서
상품코드
2106670
디지털 창상 측정 기기 : 시장 인사이트, 경쟁 구도 및 시장 예측(-2034년)Digital Wound Measurement Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034 |
||||||
DelveInsight
디지털 상처 측정 기기는 자, 아세테이트 트레이싱, 또는 육안 측정과 같은 수동적인 방법보다 높은 정확도와 일관성을 바탕으로 길이, 너비, 깊이, 면적, 부피 등 상처의 치수를 측정, 정량화, 기록하는 하드웨어 또는 소프트웨어를 활용한 시스템입니다. 당뇨병성 족부 궤양, 욕창, 정맥성 하지 궤양 등의 만성 상처는 수주에서 수개월에 걸쳐 반복적으로 평가해야 하므로, 임상의들은 이미징 센서, 구조화된 빛, 레이저 스캔 또는 컴퓨터 비전 알고리즘을 결합하여, 치유 경과에 관한 표준화되고 추적 가능한 시각적 이력을 구축하는 디지털 측정 플랫폼에 대한 의존도를 높이고 있습니다. 이러한 솔루션은 전용 하드웨어 장치나 독립형 소프트웨어 용도에 이르기까지 다양하며, 2D 이미징, 3D 이미징, AI 및 컴퓨터 비전, 레이저 기반 이미징 등의 기술을 채택하고 있으며, 접촉식 및 비접촉식 양쪽 방식으로 도입되어 당뇨병성 족부 궤양, 욕창 및 외상, 화상, 기타 상처 유형을 평가하는 데 활용되고 있습니다. 이 시장은 제품 유형별(디바이스 및 소프트웨어), 측정 기술별(2D 이미징, 3D 이미징, AI 및 컴퓨터 비전, 레이저 기반 이미징 등), 상처 유형별(당뇨병성 족부 궤양, 욕창/외상, 화상이 주를 이룸), 측정 방식별(접촉식 및 비접촉식 시스템), 최종 사용자별(병원 및 진료소가 중심)로 분류됩니다. 전 세계 만성 상처 유병률 증가, 표준화되고 감염 관리에 적합한 비접촉식 평가로의 전환, 그리고 AI를 활용한 분석 기능 및 전자건강기록(EHR)과의 연동 발전 등에 힘입어, 디지털 상처 측정 기기는 현대의 데이터 기반 상처 관리 프로그램에서 점점 더 필수적인 요소가 되고 있습니다.
디지털 상처 측정 기기 시장의 주요 성장 동인
디지털 상처 측정 기기 시장 성장에 기여하는 요인
시장 성장 촉진요인
만성 및 복합성 상처로 인한 전 세계적 부담 증가
디지털 상처 측정 기기 시장의 가장 강력한 촉진요인은 일회성 평가가 아닌, 반복적인 경과 관찰이 필요한 상처를 안고 생활하는 환자가 꾸준히 증가하고 있다는 점입니다. 만성 상처는 당뇨병, 운동 기능 저하, 혈관 기능 부전, 고령화와 밀접한 관련이 있으며, 인구 고령화가 진행되고 장기적인 질환 관리 부담이 증가함에 따라 그 존재감이 점점 더 두드러지고 있습니다. 미국에서만 650만 명 이상이 만성 상처를 앓고 있으며, 연간 약 250억 달러의 의료비가 발생하고 있습니다. 또한 독일, 호주 및 기타 선진국 시장에서도 유사한 부담이 보고되고 있습니다. 이러한 경우, 상처 평가는 일회성 측정이 아니라 경과를 추적하고, 치유 지연을 파악하며, 적시에 치료 변경을 지원하는 지속적인 과정이 됩니다. 디지털 측정 기기는 상처의 경과를 시각적으로 기록하고, 특히 여러 의료진이 여러 차례의 진료에 걸쳐 동일한 환자를 진료하는 환경에서 의료 제공업체 간의 평가 편차를 줄임으로써 이러한 요구를 충족시키고 있습니다. 상처 관리 과정이 더욱 체계화됨에 따라, 의료 제공업체들은 일관성을 높이고 추측에 기반한 판단을 줄여주는 도구를 점점 더 중요하게 여기게 되었으며, 이것이 2034년까지 시장 성장 기반이 되고 있습니다.
비접촉식·이미지 주도형 평가로의 전환
수동 및 접촉형 측정에서 비접촉·영상 주도형 평가로의 구조적 전환이 시장을 재편하고 있습니다. 비접촉형 시스템을 통해 임상의는 상처 부위를 물리적으로 만지지 않고도 평가를 수행할 수 있으며, 동시에 측정 및 기록을 지원하는 영상을 촬영할 수 있습니다. 이는 감염 관리, 환자의 편안함, 재현 가능한 경과 관찰이 극히 중요시되는 현대의 상처 관리에서 매우 중요한 요소입니다. 의료 제공업체들은 특히 대규모 병원이나 여러 거점에 걸쳐 운영되는 상처 관리 프로그램에서 임상의 간의 표준화를 지원하는 시스템을 점점 더 중시하고 있으며, 이를 통해 측정과 사진 촬영, 소프트웨어 기반 분석, 구조화된 기록 기능을 결합한 이미지 기반 플랫폼이 자나 아세테이트 트레이싱을 대체하며 시장에서 입지를 다지고 있습니다.
시장 성장 억제요인
꾸준한 성장세를 보이고 있음에도 불구하고, 디지털 상처 측정 기기 시장은 중대한 제약에 직면해 있습니다. 예산 압박과 임상 현장의 도입 현황 불균형은 여전히 현실적인 제약 요인으로 작용하고 있습니다. 많은 의료 기관, 특히 소규모 시설, 외래 진료 센터 및 비용 제약이 심한 시장에 위치한 기관들은 가격에 민감하며, 수동 측정 도구가 익숙하고 저렴하다는 한, 디지털 측정 도구는 적절하긴 하지만 필수적인 것은 아니라고 간주할 가능성이 있습니다. 워크플로우의 혼란도 또 다른 장벽이 되고 있습니다. 설령 기기가 기록의 질을 향상시켜 준다 하더라도, 절차가 늘어나거나 교육이 필요하거나 기존 기록 시스템과 원활하게 연동되지 않는 경우, 임상의들은 도입을 주저할 수 있습니다. 시장에는 영상 진단, 측정, 기록 관리 솔루션이 파편적으로 혼재되어 있어 구매 결정을 복잡하게 만들고 있으며, 공급업체는 임상적 관점뿐만 아니라 시간 절약 및 업무 효율성 측면에서도 가치를 입증해야 합니다. 병원과 외래수술센터(ASC)부터 전문 클리닉, 재택 간호에 이르기까지 매우 다양한 의료 현장에서 일관된 임상적 가치를 입증하는 것은 여전히 핵심 과제입니다. 전문 상처 치료 센터에서는 우수한 성능을 발휘하는 기기라 할지라도, 일반 병원의 병동이나 자원이 제한된 외래 환경에서는 쉽게 채택되지 않을 가능성이 있기 때문입니다. 지역별 보험 환급 제도의 차이, 신흥 시장의 디지털 인프라 부족, 그리고 기술적 역량을 측정 가능한 성과로 전환해야 할 필요성이 도입 속도를 더욱 둔화시키고 있습니다. 한편, 만성 상처 유병률 증가나 디지털 전환과 같은 근본적인 촉진요인은 여전히 확고하게 존재하고 있습니다.
Digital Wound Measurement Devices Market Summary
A digital wound measurement device is a hardware- or software-enabled system that captures, quantifies, and documents wound dimensions, such as length, width, depth, area, and volume, with greater accuracy and consistency than manual methods such as rulers, acetate tracing, or visual estimation. Because chronic wounds, including diabetic foot ulcers, pressure injuries, and venous leg ulcers, require repeated evaluation over weeks or months, clinicians increasingly rely on digital measurement platforms that combine imaging sensors, structured light, laser scanning, or computer-vision algorithms to build a standardized, traceable visual history of healing progress. These solutions span dedicated hardware devices and standalone software applications, use technologies including 2D imaging, 3D imaging, AI and computer vision, and laser-based imaging, and are deployed across contact-based and non-contact modalities to assess diabetic foot ulcers, pressure ulcers and injuries, burns, and other wound types. The market is organized by product type across devices and software; by measurement technology, including 2D imaging, 3D imaging, AI and computer vision, laser-based imaging, and others; by wound type, led by diabetic foot ulcers, pressure ulcers/injuries, and burns; by modality across contact-based and non-contact systems; and by end-user, led by hospitals and clinics. Driven by the rising global prevalence of chronic wounds, the shift toward standardized, infection-control-friendly non-contact assessment, and the integration of AI-enabled analytics and EHR connectivity, digital wound measurement devices have become an increasingly essential component of modern, data-driven wound-care programs.
Digital Wound Measurement Devices Market Key Growth Drivers
Key Companies in Digital Wound Measurement Devices Market
The competitive landscape is led by the following active device manufacturers:
Factors Contributing to the Growth of the Digital Wound Measurement Devices Market
Market Drivers
Rising Global Burden of Chronic and Complex Wounds
The most powerful driver of the Digital Wound Measurement Devices market is the steady increase in patients living with wounds that require repeated follow-up rather than one-time evaluation. Chronic wounds are closely tied to diabetes, immobility, vascular insufficiency, and advanced age, and they are becoming more visible as populations age and long-term disease management becomes more demanding. In the United States alone, over 6.5 million individuals live with chronic wounds, generating annual healthcare costs of approximately USD 25 billion, while similar burdens are reported across Germany, Australia, and other developed markets. In these cases, wound assessment is not a single measurement but an ongoing process of tracking progress, identifying delayed healing, and supporting timely changes in treatment. Digital measurement devices meet this need by creating a visual history of the wound and reducing variation between caregivers, particularly in settings where multiple clinicians see the same patient across several visits. As wound-care pathways become more structured, providers increasingly value tools that improve consistency and reduce guesswork, anchoring market growth through 2034.
Shift Toward Non-Contact, Imaging-Led Assessment
A structural shift away from manual and contact-based measurement toward non-contact, imaging-led assessment is reshaping the market. Non-contact systems allow clinicians to assess wounds without physically touching the site while capturing images that support measurement and documentation, which matters in modern wound care where infection control, patient comfort, and repeatable follow-up carry real weight. Providers increasingly value systems that support standardization across clinicians, especially in large hospitals and multi-site wound programs, helping imaging-based platforms that combine measurement with photo capture, software analysis, and structured documentation gain ground over rulers and acetate tracing.
Market Restraints
Despite steady momentum, the Digital Wound Measurement Devices market faces material constraints. Budget pressure and uneven clinical adoption remain a practical restraint, as many providers, particularly smaller facilities, outpatient centers, and institutions in cost-constrained markets, remain price-sensitive and may view digital measurement tools as appropriate but not essential when manual tools remain familiar and inexpensive. Workflow disruption is a further barrier: even when a device improves documentation quality, clinicians may hesitate to adopt it if it adds steps, requires training, or does not integrate smoothly with existing records systems. The market includes a fragmented mix of imaging, measurement, and documentation solutions, complicating purchasing decisions and requiring vendors to prove value not only in clinical terms but also in time savings and operational efficiency. Proving consistent clinical value across highly varied care settings, from hospitals and ambulatory surgical centers to specialty clinics and home-based care, remains a core challenge, since a device that performs well in a specialized wound center may not be readily adopted in a general hospital ward or resource-limited outpatient setting. Reimbursement variability across geographies, limited digital infrastructure in emerging markets, and the need to translate technical capability into measurable outcomes further temper the pace of adoption, even as the underlying drivers of chronic-wound prevalence and digital transformation remain firmly intact.
Digital Wound Measurement Devices Market Segment Analysis
The Digital Wound Measurement Devices by Market by Product Type (Devices and Software), Measurement Technology (2D Imaging, 3D Imaging, AI & Computer Vision, Laser-Based Imaging, and Others), Wound Type (Diabetic Foot Ulcers, Pressure Ulcers/Injuries, Burns, and Others), Modality (Contact-Based and Non-Contact), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of World).
By Product Type
Dominant Subsegment: Software.
Dominant: Software ~ 58%
The software segment accounted for 58% of the Digital Wound Measurement Devices market in 2025. Software is the leading product type because wound-care providers increasingly value the analytics, documentation, and EHR-integration layer as much as the underlying imaging hardware. Software platforms such as ARANZ Medical's Silhouette, eKare's inSight, and Net Health's Tissue Analytics deliver automated measurement, wound-progression tracking, and structured clinical records on top of standard smartphones or tablets, lowering the incremental hardware cost of adoption while enabling recurring, subscription-based revenue for vendors. The proliferation of smartphone-based imaging and cloud-hosted analytics has expanded software's reach into specialty clinics and home-based settings where dedicated hardware purchases are harder to justify.
While dedicated devices, including near-infrared and fluorescence-imaging hardware such as Kent Imaging's SnapshotNIR and MolecuLight's point-of-care imaging systems, continue to grow steadily on the strength of differentiated clinical capability, the breadth, scalability, and recurring-revenue economics of software platforms secure the segment's leadership across the forecast period.
By Measurement Technology
Dominant Subsegment: 2D Imaging.
Dominant: 2D Imaging ~ 50%
The 2D imaging segment accounted for 50% of the Digital Wound Measurement Devices market in 2025. 2D imaging is the leading measurement technology because it balances utility, cost, and ease of use. Two-dimensional imaging platforms give clinicians a fast, low-cost way to capture wound images, estimate dimensions, and build a visual timeline without the capital investment or learning curve associated with more advanced 3D or laser-based systems, making them the practical default across hospitals, specialty clinics, and lower-resource care settings.
AI and computer vision are the fastest-growing measurement technology, as platforms increasingly combine machine learning with structured light and photogrammetry to automate wound-border delineation and tissue classification, while 3D imaging is also expanding quickly on the strength of its ability to capture depth and volume, both critical for tracking healing in cavity wounds and deep pressure injuries. Laser-based imaging remains a smaller, specialized category valued for measurement precision in dedicated wound-care centers.
Digital Wound Measurement Devices Market Region Analysis
Dominant Region: North America
North America accounted for 42% of the global Digital Wound Measurement Devices market revenue in 2025, representing the highest regional market share globally. The region's leadership reflects advanced healthcare infrastructure, high adoption of medical imaging and digital documentation tools, and a strong presence of wound-care specialists across hospitals and outpatient settings. North America hosts the largest concentration of digital wound-care platform vendors, including ARANZ Medical, MolecuLight, eKare, Kent Imaging, and Net Health, and benefits from established reimbursement pathways and regulatory clarity through the FDA. The rising burden of chronic wounds, including diabetic foot ulcers and pressure injuries, combined with strong institutional purchasing power and EHR interoperability standards, drives substantial outsourced-imaging and software adoption. Continued investment, including MolecuLight's USD 27.5 million capital raise and Net Health's acquisition activity, is reinforcing the region's leadership across the forecast period.
Fastest Growing Region: Asia-Pacific
Asia-Pacific is the fastest-growing region in the Digital Wound Measurement Devices market. The region's elevated CAGR is driven by expanding healthcare infrastructure, rising diabetes and chronic-wound prevalence, and growing awareness of digital wound-assessment tools across China, Japan, India, South Korea, and Australia. China is expanding hospital digitization and imaging infrastructure, Japan is integrating advanced wound-care technologies into its aging-population health strategy, and India is emerging as a growth market on the back of a large and rising diabetic population and expanding private hospital networks. Government healthcare investment, growing wound-care awareness, and the entry of global vendors into regional distribution partnerships are accelerating adoption, positioning Asia-Pacific as the principal source of incremental growth over the forecast period.
Regional Commentary
North America
North America accounted for 42% of the global Digital Wound Measurement Devices market revenue in 2025. The United States dominates on the strength of its advanced wound-care infrastructure, digital-health adoption, FDA regulatory clarity, and concentration of leading device and software vendors, while continued capital investment and EHR-integration initiatives reinforce the region's leadership.
Europe
Europe is a large and advanced regional market, supported by an aging population, rising chronic-wound incidence affecting up to 14.9 million people, and growing institutional focus on standardized wound-care quality. Vendors such as ARANZ Medical are expanding regional partnerships, while providers such as Smith & Nephew are showcasing integrated wound-care innovation at forums including the European Wound Management Association conference, reinforcing the region's role as a mature, quality-driven market across Germany, the United Kingdom, France, Italy, and Spain.
Asia-Pacific
Asia-Pacific is the fastest-growing region, propelled by expanding healthcare infrastructure, rising diabetes and chronic-wound prevalence, and growing digital-health investment across China, Japan, India, South Korea, and Australia. Expanding hospital networks and rising awareness of standardized, non-contact wound assessment are accelerating regional adoption and clinical-partnership activity.
Rest of World
The Rest of World region, spanning Latin America, the Middle East, and Africa, is an emerging growth frontier. Expanding hospital infrastructure, rising diabetes prevalence, and gradual adoption of digital documentation practices are broadening access, while international distribution partnerships support the build-out of regional wound-care imaging capacity.
Digital Wound Measurement Devices Market Competitive Landscape
The Digital Wound Measurement Devices market is classified as Moderately Fragmented. A group of established medical-technology players with broad wound-care portfolios and global distribution, including Smith & Nephew and Stryker, compete alongside specialized imaging and software innovators such as MolecuLight, ARANZ Medical, eKare, Kent Imaging, WoundVision, and Net Health, which differentiate through measurement accuracy, AI-enabled analytics, and EHR integration. Emerging players including WoundMatrix, Perceptive Solutions, and BioVisual Technologies compete through focused product innovation and channel partnerships, increasing competition in the fastest-growing non-contact and AI-enabled segments.
The competitive landscape can be evaluated across the following dimensions:
Digital Wound Measurement Devices Market Recent Developmental Activities
In December 2025, Kent Imaging Inc. signed an exclusive U.S. distribution agreement with New Horizon Medical Solutions covering all 48 contiguous states for its Snapshot family of near-infrared and bacterial-autofluorescence imaging devices, including SnapshotNIR and SnapshotGLO. Strategic significance: Expands U.S. commercial reach and strengthens Kent Imaging's position in point-of-care perfusion and bioburden imaging.
In January 2026, Net Health opened registration for its NEXT client conference and continued expanding its AI-native wound-care and outcomes-analytics platform across its restorative-care software portfolio. Strategic significance: Reinforces Net Health's software leadership and deepens client engagement across its wound-care EHR ecosystem.
Digital Wound Measurement Devices Market Segmentation
Digital Wound Measurement Devices Market by Product Type
Digital Wound Measurement Devices Market by Measurement Technology
Digital Wound Measurement Devices Market by Wound Type
Digital Wound Measurement Devices Market by Modality
Digital Wound Measurement Devices Market by End-User
Digital Wound Measurement Devices Market by Geography
Key Takeaways from the Digital Wound Measurement Devices Market Report Study
Target audience who can benefit from this Digital Wound Measurement Devices market report study
Q1. What is the growth rate of the digital wound measurement devices market?
The digital wound measurement devices market is projected to expand at a CAGR of 8.5% during the forecast period from 2026-2034.
Q2. What is the market size of the digital wound measurement devices market?
The digital wound measurement devices market is estimated at USD 260.5 million in 2025 and is projected to reach USD 552.7 million by 2034.
Q3. Which region dominates the digital wound measurement devices market?
North America dominated the digital wound measurement devices market with a 42% share of global revenue in 2025, supported by advanced healthcare infrastructure, high adoption of digital documentation tools, strong reimbursement pathways, and the largest concentration of leading device and software vendors. Asia-Pacific is the fastest-growing region over the forecast period.
Q4. What are the key drivers of the digital wound measurement devices market?
The principal drivers are the rising global burden of chronic and complex wounds, including diabetic foot ulcers and pressure injuries; the structural shift toward non-contact, imaging-led assessment; growing integration of AI and computer vision into wound-imaging platforms; rising investor and strategic interest, exemplified by MolecuLight's USD 27.5 million capital raise; and the push for standardized documentation and reimbursement support.
Q5. Who are the major players in the digital wound measurement devices market?
The major players include MolecuLight Inc., WoundMatrix, Inc., Kent Imaging Inc., ARANZ Medical Limited, WoundVision LLC, Stryker, eKare Inc., Net Health, Perceptive Solutions, Inc., and BioVisual Technologies LLC, among other active providers profiled in the Competitive Landscape section, along with Smith & Nephew and Swift Medical Inc. ARANZ Medical, MolecuLight, Net Health, and Smith & Nephew lead through installed base, distribution reach, and clinical validation.
For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.